| Literature DB >> 34407128 |
Victoria von Salmuth1, Eilise Brennan1,2, Marko Kerac1,3, Marie McGrath2, Severine Frison4, Natasha Lelijveld2.
Abstract
BACKGROUND: Small and nutritionally at-risk infants under 6 months (<6m) are a vulnerable group at increased risk of mortality, morbidity, poor growth and sub-optimal development. Current national and international (World Health Organization) management guidelines focus mainly on infants' needs, yet growing evidence suggests that maternal factors also influence infant outcomes. We aimed to inform future guidelines by exploring the impacts of maternal-focused interventions on infant feeding and growth.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34407128 PMCID: PMC8372927 DOI: 10.1371/journal.pone.0256188
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary of maternal supplementation interventions, during lactation and pregnancy–reviews.
| Study | Intervention | Outcome measures | Outcomes article | Review quality | Reported quality of primary evidence |
|---|---|---|---|---|---|
|
| |||||
|
| Food and fortified food product, macronutrient interventions, counselling plus food | Birth weight, LBW, weight, SGA, head circumference macrosomia, large for gestational age, perinatal mortality | High | Positive (61%) and neutral (39%) quality | |
|
| Food distribution and supplementary feeding programmes | SGA, stillbirth, birth weight, birth length, height gain, weight gain, neonatal death | Impacted stillbirth (RR 0.60, CI 0.39 to 0.94), infant birth weight (MD 40.96, CI 4.66 to 77.26), SGA, birth length (MD 0.16 CI 0.10 to 0.31). No long-term benefits for the child in terms of growth and neurocognitive development. | High | Very low-moderate quality |
| High protein supplementation was associated with increased risk of SGA. | |||||
|
| Balanced protein energy supplementation in undernourished women | Birth weight, birth length, head circumference, physical growth | Impacted birth weight (MD 0.20g, CI 0.03 to 0.38g). | High | Low (28.2%), moderate (43.6%) and high (28.2%) quality |
| No significant effect on birth length and head circumference. | |||||
| Impact on long-term growth is inconclusive–One RCT which showed a significant difference in height till 60 months and weight until 24 months. | |||||
|
| Balanced protein energy supplementation | SGA, neonatal mortality, birth weight | Impact SGA (RR 0.69, CI 0.56 to 0.85), birth weight (MD 59.89g, CI 33.09 to 86.86g), effect was more pronounced in malnourished women. | High | Overall moderate quality |
| No impact on neonatal mortality. | |||||
|
| Protein from animal-sourced foods | Birth weight, LBW, SGA, height, and length | Impacted birth weight (MD 0.06kg, CI 0.02 to 0.11kg) and maternal weight gain. No impact LBW, SGA, height or weight in later childhood. | High | Low (34%), moderate (255) and high (41%) quality |
|
| MMN supplementation | LWB, birth weight, SGA, gestational age, preterm birth, stillbirth, neonatal death, maternal mortality | Impacted LBW (RR 0.86, CI 0.81 to 0.91), birthweight (MD 52.6g, CI 43.18 to 62.03g), SGA RR 0.83, CI 0.73 to 0.95), gestational age (WMD 0.08 weeks, CI 0.01 to 0.14 weeks). | High | Overall moderate-high quality |
| No impact preterm, stillbirth, neonatal death, maternal mortality; increased risk of neonatal death when compared with iron–folate in the subgroup of five trials that began after the first trimester (RR 1.38, CI 1.05 to 1.81). No impact maternal mortality (RR 0.96, CI 0.64 to 1.45). | |||||
|
| Vitamin A and carotenoids | LBW, SGA, birth weight, weight gain in pregnancy, preterm birth, gestational age, neonatal mortality, morbidity, infant and child growth, mortality and morbidity, maternal mortality, pre-eclampsia, maternal anaemia | No impact on SGA and birth weight, preterm, stillbirth foetal death, maternal mortality, morbidity or birth complications, infants and neonatal mortality; no impact of mother-to-child HIV transmission in a pooled analysis, although some evidence suggests that it may increase transmission. | High-moderate | Overall low-moderate quality; very low (10%), low (45%), moderate (21%) and high (24%) quality |
| Impact on LBW for HIV+ populations (RR 0.79, CI 0.64 to 0.99). | |||||
| Little evidence of an effect on WAZ and HAZ. | |||||
| Improved haemoglobin levels and risk of anaemia (RR 0.81, CI 0.69 to 0.94) | |||||
|
| Lipid-based nutrient supplement | Maternal anthropometric status, maternal mortality, adverse maternal outcomes, LBW, birth weight, birth length, SGA, preterm, child development, duration of gestation, stillbirths, head circumference, infant mortality, neonatal mortality, MUAC, stunting, wasting and underweight in the first 6 months. | High | Overall moderate quality | |
|
| Omega-3 fatty acids | Preterm, gestation, perinatal deaths, LBW, Large for gestational age, SGA, intrauterine growth restrictions, adverse maternal effects, child neurodevelopment and growth, adult body mass index | Positive impact on preterm birth (RR 0.89, CI 0.81 to 0.97), perinatal deaths (RR 0.75, CI 0.54 to 1.03) and LBW (RR 0.90, CI 0.82 to 0.99); Small increase large for gestational age (RR 1.15, CI 0.97 to 1.36), little/no difference in SGA or intrauterine growth restrictions. | High | Very low-moderate quality |
| Little difference in child neurodevelopment and growth outcomes | |||||
| insufficient evidence to determine effects on maternal adverse events and postnatal depression | |||||
|
| Iodine | Perinatal mortality, LBW, preterm birth, SGA, infant/child physical and mental development, mortality, Impacted postpartum hyperthyroidism and digestive intolerance in pregnancy | Positive impact perinatal mortality (RR 0.66, CI 0.42 to 1.03), congenital anomalies (RR 0.27, CI 0.12 to 0.60), uncertain data on neonatal mental/motor development but higher child mental development score (MD 11.21, CI 7.97 to 14.46) | High | Overall very low-low quality |
| Impacted postpartum hyperthyroidism (RR 0.32, CI 0.11 to 0.91) and digestive intolerance in pregnancy (RR 15.33, CI 2.07 to 113.7) | |||||
| No trials reported on infant/child growth or infant death; No impact LBW, preterm or SGA; All data from regions with mild to moderate iodine deficiency. | |||||
|
| Iodine | Birth length, weight, and head circumference | High | Overall very low quality | |
|
| Iodine | Child development and growth | High-moderate | None of the studies reported adequate random-sequence generation, high risk of bias due to incomplete data, unclear risk for blinding due to inadequate reporting | |
|
| Vitamin E | Preeclampsia, preterm, stillbirth, neonatal death, perinatal death, intrauterine growth restrictions, maternal death, maternal morbidity, infant death, gestational age, child growth, congenital malformations, Apgar score | No impact stillbirth, neonatal death, infant death, preterm, pre-eclampsia, intrauterine growth restrictions, birth weight, maternal death, gestational age, congenital malformations, Apgar score, maternal morbidity/adverse effects. | High | Majority moderate-high quality but low for preterm PROM |
| Increased risk self‐reported abdominal pain (RR 1.66, CI 1.16 to 2.37) and term prelabour rupture of membranes (PROM) (RR 1.77, CI 1.37 to 2.28); no corresponding increased risk for preterm PROM. No data on child growth. | |||||
|
| Vitamin C | Stillbirth, neonatal death, perinatal death, intrauterine growth retardation, preterm, maternal death, infant death, gestational age, birth weight, congenital malformations, poor childhood growth, PROM, eclampsia | No impact on stillbirth, neonatal death, intrauterine growth restriction, perinatal death, preterm birth, preterm PROM, term PROM, maternal death, eclampsia, infant death congenital malformations, birth weight; no reported adverse effects. | High | Majority moderate-high quality but low for preterm PROM |
| Impacted gestational age (MD 0.31, CI 0.01 to 0.61) and the risk of self-reported abdominal pain. | |||||
| Risk of term and preterm PROM differed by type of supplementation–reduced risk for term and preterm PROM when supplemented alone, but increased risk when supplementation included vitamin C and E (RR 1.73, CI 1.34 to 2.23) | |||||
|
| B12 | Birth weight, LBW, SGA, preterm | No associations between B12 levels and birth weight but B12-deficiency was associated with an increased risk of LBW (RR1.15, CI 1.01 to 1.31) and higher B12 was associated with higher birth weight in LMIC. Linear association between maternal levels of B12 and risk of preterm birth (0.89 per one SD increase (CI 0.82 to 0.97). | High-moderate | Overall moderate-high quality |
|
| Magnesium | Perinatal mortality, maternal mortality, pre-eclampsia, stillbirths, neonatal death prior to discharge, preterm, birth weight, LBW, gestational age | No impact perinatal mortality, SGA, stillbirth, LBW, pre-eclampsia; No data on maternal death; Increase in neonatal death (RR 2.21, CI 1.02–4.75); fewer babies with an Apgar score less (RR 0.34, CI 0.15 to 0.80). | High | Lack of high-quality evidence; selective reporting unclear for all trials; 20% of trials high risk due to rack of blinding of participants |
|
| Zinc | Preterm, LBW, SGA, birth weight, gestational age, head circumference | Impacted preterm (RR 0.86, CI 0.75 to 0.99); no effect on LBW, SGA, birth weight, gestational age, head circumference. | High | Overall very low-low |
|
| Calcium | Preterm birth, LBW, maternal death, maternal weight, perinatal mortality, neonatal death, birth length, head circumference, intrauterine growth restrictions, mineral bone density | Impacted birth weight (MD 56.40g, CI 13.55 to 99.25g), and infant total and tibial bone mineral density. | High | Overall moderate quality |
| No impact LBW, or preterm birth, maternal death, perinatal mortality, birth length, head circumference, intrauterine growth restrictions, maternal bone mineral density. No data on neonatal death. | |||||
|
| Folic Acid | Preterm birth, stillbirths/neonatal death, pre-eclampsia, LBW, birth weight, maternal haemoglobin | No impact preterm, no impact on stillbirth/neonatal deaths, LBW and mean birth weight, maternal haemoglobin. | High | Included studies old (30 to 45 years ago); outcome measurement varied, poor compliance with random allocation, concealment and blinding. Bias and confounding seemed likely explanations for findings |
|
| |||||
|
| Vitamin D | Infant growth, birth weight, LBW, morbidity, and mortality | Positive impact SGA (RR 0.72, CI 0.52 to 0.99), risk of foetal/neonatal mortality (RR 0.72, CI 0.47 to 1.11) or cognitive abnormalities (RR 0.94, CI 0.61 to 1.43), birth weight (MD, 75.38g, CI 22.88 to 127.88 g), and weight at 3, 6, 9, and 12 months. No significant difference in LBW or preterm birth. | High | Majority low/unclear risk of bias |
|
| Vitamin D | Pre-eclampsia, SGA, LBW, preterm, birth weight, birth length | Impact on birth weight (MD 107.6g, CI 59.9 to 155.3g), and birth length (MD 0.3cm, CI 0.1 to 0.41cm). No impact on pre-eclampsia, SGA, LBW and preterm birth. | High | Majority unclear/low risk of bias |
| Low risk of bias for all studies for incomplete data, selective reporting and other sources | |||||
|
| Vitamin D | Preeclampsia, SGA, birth weight and length | Increase in infant 25 (OH)D concentration, and birth weight (MD 114.2g, CI 63.4 to 165.1g). No impact on SGA and birth length or pre-eclampsia. | High | Overall fair quality |
|
| Vitamin D | LBW, SGA, birth weight, length, and head circumference | Positive impact birth weight (MD 103.17g, CI 62.29 to 122.04g), birth length (MD 0.50 cm, CI 0.08 to 0.92cm), head circumference (MD 0.19cm, CI 0.1 to 0.24cm), LBW (RR 0.40, CI 0.22 to 0.74), SGA (RR 0.69, CI 0.51 to 0.92); all outcomes impacted with Vit D supplemented alone, no impact when combined with other micronutrients. | High | Ranged very low (head circumference) to moderate quality (birth weight, birth length, LBW, and SGA) |
|
| |||||
|
| Extra fluids for breastfeeding mothers for increasing milk production. | Weight gain; EBF duration; Breastmilk production | No data on LMIC found despite inclusion in the search. Only one study met the inclusion criteria: reported no impact on breastmilk production (measured using test weighting) following advice to mothers to drink extra fluids. No data on other primary or secondary infant outcomes. | High-moderate | Low-quality |
|
| Oral galactagogues | Continued breastfeeding, infant weight, milk volume | High | Very low-low quality | |
| Uncertain of adverse effect for mothers, those reported were minor complaints. | |||||
|
| MMN and polyunsaturated fatty acid supplementation. | Infant and child mortality, morbidity, and growth: weight, length, head circumference, WAZ, length-for-age z score | Moderate-low | Not available for all outcomes: Wide range very low-high | |
| Polyunsaturated fatty acid supplementation vs placebo: no impact infant length, weight and head circumference | |||||
| Polyunsaturated fatty acid supplementation during gestation and lactation: no significant growth effects, some evidence for impact on child attention beyond 24 months of age. | |||||
| An RCT of maternal calorie supplementation + breastfeeding support: no impact WAZ or length for age z score; Increased infant breast milk intake and EBF. | |||||
|
| MMN | Infant mortality, morbidity, adverse effects within three days of supplementation | No evidence to quantitatively assess the effectiveness of MMN supplementation in improving health outcomes in mother and baby. | High-moderate | Poorly reported among original studies; unclear risk of bias |
| Impact on maternal anaemia (1 study) and vitamin B12 and folic acid milk concentration, but no significant dereferences were reported in serum concentrations (1 study). | |||||
|
| |||||
|
| Low does iron and zinc via supplementation or fortification | Birth weight, LBW, HAZ, WAZ, WHZ, mental and motor development, morbidity. | High-moderate | Majority low-moderate quality | |
Standard mean difference (SMD); Height-for-age z score (HAZ); Weight-for-age z score (WAZ); Mid-upper arm circumference (MUAC); Weight-for-height z scores (WHZ); Small for gestational age (SGA); Mean difference (MD); Relative risk (RR); Low birth weight (LBW); Randomised control trails (RCTs); Multiple micronutrients (MMN); Premature rupture of membranes (PROM); Low middle-income countries (LMIC).
*Quality reported in the respective review.
Summary of maternal non-supplementation interventions during lactation and pregnancy-reviews.
| Study | Intervention | Outcome measures | Summary of findings (separated into prevention and management) | Review quality | Reported quality of primary evidence |
|---|---|---|---|---|---|
|
| |||||
|
| Breastfeeding promotion interventions | Weight, length/height z scores, body mass index, WHZ | High-moderate | High-quality evidence (26%); very low/low risk of bias (46%); high risk of bias (29%) | |
|
| Breastfeeding support: Community based one-on-one and/or group peer support | Underweight, stunting, wasting, child feeding practices (birth-6 months) | High | ||
|
| Breastfeeding and complementary feeding education | EIBF, EBF, HAZ, WAZ, WHZ, neonatal mortality, infant mortality | High | ||
|
| Community home visits and mother/peer groups promoting child health, nutrition and feeding practices. | EIBF, EBF, minimum dietary diversity, minimum meal frequency, stunting, underweight and wasting | High | ||
|
| Educational intervention on the introduction of complementary feeding | Weight, height/length, MUAC, WAZ, height/length age z score, weight for height/length z score, morbidity, mortality | High | ||
|
| Community-based health education care packages | Neonatal mortality, perinatal mortality, neonatal infections, and health behaviours. | High | ||
|
| Nutrition education interventions for infant weaning | WAZ, HAZ, child growth and neuro-development | Increased WAZ (MD 0.15, CI 0.07 to 0.22) and HAZ (MD 0.12, CI 0.05 to 0.19) by 12 months of age. Uncertain effects on long-term growth and neuro-development outcomes. | High | |
|
| |||||
|
| Water intervention, coverage / use sanitation facilities, handwashing w/soap | WHZ, WAZ, or HAZ | High | ||
|
| Hygiene promotion, education, water intervention, sanitation improvement | Weight, height, WHZ, MUAC, prevalence malnutrition, non-diarrheal morbidity, infant mortality | Moderate | Majority very low quality | |
|
| Water treatment, hand washing, hygiene education, home based water treatment, latrine construction/promotion | Child nutritional status, HAZ | High | Most studies had low risk of bias | |
|
| |||||
|
| Gender accommodating-/ transformative, Behaviour Change Communication | Infant mortality, stunting | Moderate-low | Not formally assessed, only included studies with moderate-to-strong evaluation designs | |
|
| Gender empowerment, family planning, health, nutrition, agriculture, WASH, financial services | Stunting, wasting, underweight, body mass index, MUAC, length/age weight/age, weight/length | Moderate | Not formally assessed, reported that strength of design and analyses varied; limited RCT’s and quasi-experimental studies | |
|
| |||||
|
| Relaxation therapy | Infant dietary intake, weight gain, body mass index, breastfeeding (breast milk volume/ milk yield) | High-moderate | All studies had limitations regarding design or sample collection procedures–(2/5) not randomised, studies unable to blind participates, many had small sample sizes, did not consider all potential confounders | |
|
| |||||
|
| MMN, folic acid, iron/iron folic acid, calcium, iodine, vitamin D, zinc and balanced energy and protein supplementation, nutrition education, WASH interventions, deworming, IPTp/ITN for malaria in pregnancy, mental health support. | Growth, stunting wasting, mortality, breastfeeding, complementary feeding practices (6–24 months) | High-moderate | Not reported, however, only captured reviews with good quality methods for all interventions. | |
|
| Zinc, micronutrient and macro nutrition supplementation and nutrition education. | length-for-age/HAZ birth weight, LBW | High | ||
|
| Agriculture, Social safety nets, Early child development | Maternal and child nutritional status | Moderate | Not formally assessed, however, reported that studies often suffered from poor quality impact evaluations | |
|
| Large scale iron folic acid, food supplementation/ nutrition education, counselling/ + conditional cash transfers programmes | Birth weight, maternal weight gain, caregiver knowledge, behavioural change, dietary habits, anaemia | Low | Not formally assessed, only large scale programs that were adequately evaluated were utilised, high risk of publication bias for grey lit | |
|
| Micronutrient supplementation, lipid-based supplementation or food supplementation, deworming, maternal education, and WASH. | Preterm birth, birth weight, length-for-age z score | High |
| |
| No intervention for mothers with infants 0-6months led to statistically significant improvements in length-for-age z score. | |||||
|
| MMN, iron folic acid, Vit D lipid based nutrient supplements, deworming, WASH, food provision and maternal education | Length-for-age z score | High |
| |
|
| Nutrition education and balanced energy and protein supplementation | Preterm, birth weight, neonatal death, child growth, still birth, neurological development | High | Majority low-moderate quality | |
|
| Social support via home visits, antenatal clinic visits, telephone or combination for women at increased risk of LBW babies | Birth weight, stillbirth/neonatal death, gestational age, infant morbidity, postnatal depression | High | Overall: moderate quality | |
|
| |||||
|
| Interventions using mobile Health technologies | Birth weight, growth, breastfeeding initiation/duration; pregnancy weight gain, maternal knowledge | High-moderate | Only 4 studies captured but all studies were positive/neutral quality | |
|
| Targeted client communication via mobile phones. | Health behaviour change, service utilisation e.g. antenatal care, maternal morbidity/mortality, maternal morbidity (mental), neonatal health, partner violence, well-being, acceptability. | High | ||
|
| Unidirectional text/voice messaging, direct two-way communication, multidirectional text messages, unidirectional telephone counselling | Maternal and neonatal service utilisation, maternal health, mortality and morbidity, perinatal mortality, maternal knowledge. | High-moderate | ||
| Inconclusive findings were observed for mHealth effects on maternal knowledge but positive effects on service utilisation. | |||||
|
| |||||
|
| Conditional cash transfers with or without micronutrient- fortified food, health nutritional education | Height, HAZ, weight, weight-for length, WAZ, child micronutrient status | Moderate-low | Not formally assessed, however reported low publication bias | |
|
| Conditional cash transfers, to households +/- nutrition supplementation | Weight, growth, height, HAZ, WAZ children <24 months, stunting, underweight | High | Moderate quality for all outcome apart from health service utilisation (low quality) | |
|
| |||||
|
| Bio-fortification, home gardens, small scale fisheries/ aquaculture, dairy development | Height-for-age, weight-for-age, weight-for-height, prevalence stunting, wasting, underweight, micronutrient intake | Moderate | Studies were not of high quality, high overall risk of bias; bias introduced due to the low number of RCT’s, high selection bias, small samples sizes, lack of power calculations and outcomes measurements. | |
Height-for-age z score (HAZ); weight-for-age z score (WAZ); mid-upper arm circumference (MUAC); small for gestational age (SGA); Mean difference (MD); Relative risk (RR); low birth weight (LBW); Randomised control trials (RCTs); multiple micronutrients (MMN); Water sanitation and hygiene (WASH); intermittent prevention treatment in pregnancy/insecticide treated bed nets (IPTp/ITN); weight-for-height z scores (WHZ); Early initiation of breastfeeding (EIBF); Exclusive breastfeeding (EBF): Odds ratio (OR); Standard mean difference (SMD).
*Quality reported in the respective reviews
** Prevention of growth faltering in infants <6m
***Management of small and nutritionally at-risk infants <6m.